Access the full text.
Sign up today, get DeepDyve free for 14 days.
Kei Nagai, T. Sairenchi, F. Irie, Hiroshi Watanabe, H. Ota, K. Yamagata (2016)
Relationship between Estimated Glomerular Filtration Rate and Cardiovascular Mortality in a Japanese Cohort with Long-Term Follow-UpPLoS ONE, 11
I. Masakane, S. Nakai, S. Ogata, N. Kimata, N. Hanafusa, T. Hamano, K. Wakai, Atsushi Wada, K. Nitta (2015)
An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013)Therapeutic Apheresis and Dialysis, 19
Tse-Ya Yu, Hung-Yuan Li, Yi‐Der Jiang, Tien-Jyun Chang, Jung‐Nan Wei, L. Chuang (2013)
Proteinuria predicts 10-year cancer-related mortality in patients with type 2 diabetes.Journal of diabetes and its complications, 27 3
T. Konta, Zhimei Hao, S. Takasaki, H. Abiko, Mizue Ishikawa, Toshiyuki Takahashi, Ami Ikeda, K. Ichikawa, T. Kato, S. Kawata, I. Kubota (2007)
Clinical utility of trace proteinuria for microalbuminuria screening in the general populationClinical and Experimental Nephrology, 11
K. Tsuruya, H. Yoshida, M. Nagata, T. Kitazono, K. Iseki, C. Iseki, S. Fujimoto, T. Konta, T. Moriyama, K. Yamagata, I. Narita, K. Kimura, M. Kondo, K. Asahi, I. Kurahashi, Y. Ohashi, Tsuyoshi Watanabe (2015)
Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population.American journal of kidney diseases : the official journal of the National Kidney Foundation, 66 6
A. Kashiwagi, M. Kasuga, E. Araki, Y. Oka, T. Hanafusa, Hiroshi Ito, M. Tominaga, S. Oikawa, Mitsuhiko Noda, T. Kawamura, T. Sanke, M. Namba, M. Hashiramoto, T. Sasahara, Y. Nishio, K. Kuwa, K. Ueki, I. Takei, M. Umemoto, M. Murakami, M. Yamakado, Y. Yatomi, H. Ohashi (2012)
International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program valuesJournal of Diabetes Investigation, 3
S. Hallan, Marius Øvrehus, S. Romundstad, D. Rifkin, A. Langhammer, P. Stevens, J. Ix (2016)
Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway.Kidney international, 90 3
M. Kondo, K. Yamagata, S. Hoshi, Chie Saito, K. Asahi, T. Moriyama, K. Tsuruya, T. Konta, S. Fujimoto, I. Narita, K. Kimura, K. Iseki, Tsuyoshi Watanabe (2014)
Budget impact analysis of chronic kidney disease mass screening test in JapanClinical and Experimental Nephrology, 18
Y. Mok, K. Matsushita, Y. Sang, S. Ballew, M. Grams, S. Shin, S. Jee, J. Coresh (2016)
Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart StudyPLoS ONE, 11
Jinwei Wang, Junjuan Li, Anxin Wang, Jianli Wang, Yaozheng Yang, Shuohua Chen, Shouling Wu, Minghui Zhao, Xiuhua Guo, Luxia Zhang (2017)
Dipstick proteinuria and risk of myocardial infarction and all-cause mortality in diabetes or pre-diabetes: a population-based cohort studyScientific Reports, 7
A. Levey, K. Eckardt, Y. Tsukamoto, A. Levin, J. Coresh, J. Rossert, D. Zeeuw, T. Hostetter, N. Lameire, G. Eknoyan (2005)
Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney international, 67 6
K. Iseki, T. Konta, K. Asahi, K. Yamagata, S. Fujimoto, K. Tsuruya, I. Narita, M. Kasahara, Y. Shibagaki, T. Moriyama, M. Kondo, C. Iseki, Tsuyoshi Watanabe (2018)
Association of dipstick hematuria with all-cause mortality in the general population: results from the specific health check and guidance program in JapanNephrology Dialysis Transplantation, 33
J. Carrero, M. Grams, Y. Sang, J. Ärnlöv, Alessandro Gasparini, K. Matsushita, A. Qureshi, M. Evans, P. Bárány, B. Lindholm, S. Ballew, A. Levey, R. Gansevoort, C. Elinder, J. Coresh (2017)
Albuminuria changes are associated with subsequent risk of end-stage renal disease and mortality.Kidney international, 91 1
Kenichi Tanaka, Tsuyoshi Watanabe, A. Takeuchi, Y. Ohashi, K. Nitta, T. Akizawa, S. Matsuo, E. Imai, H. Makino, A. Hishida (2017)
Cardiovascular events and death in Japanese patients with chronic kidney disease.Kidney international, 91 1
Luxia Zhang, Jianyan Long, Wenshi Jiang, Ying Shi, Xiangxiang He, Zhiye Zhou, Yanwei Li, R. Yeung, Jinwei Wang, K. Matsushita, J. Coresh, Ming-hui Zhao, Haibo Wang (2016)
Trends in Chronic Kidney Disease in China.The New England journal of medicine, 375 9
J Coresh, TC Turin, K Matsushita, Y Sang, SH Ballew, LJ Appel (2014)
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality: a meta-analysis from the CKD Prognosis ConsortiumJAMA, 311
K. Iseki, K. Asahi, T. Moriyama, K. Yamagata, K. Tsuruya, H. Yoshida, S. Fujimoto, T. Konta, I. Kurahashi, Y. Ohashi, Tsuyoshi Watanabe (2012)
Risk factor profiles based on estimated glomerular filtration rate and dipstick proteinuria among participants of the Specific Health Check and Guidance System in Japan 2008Clinical and Experimental Nephrology, 16
D. Goodkin, E. Young, K. Kurokawa, K. Prütz, N. Levin (2004)
Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects.American journal of kidney diseases : the official journal of the National Kidney Foundation, 44 5 Suppl 2
E. Imai, K. Yamagata, K. Iseki, H. Iso, M. Horio, H. Mkino, A. Hishida, S. Matsuo (2007)
Kidney disease screening program in Japan: history, outcome, and perspectives.Clinical journal of the American Society of Nephrology : CJASN, 2 6
Hiroko Sato, T. Konta, K. Ichikawa, Natsuko Suzuki, Asami Kabasawa, Kazuko Suzuki, A. Hirayama, Y. Shibata, Tetsu Watanabe, T. Kato, Y. Ueno, T. Kayama, I. Kubota (2015)
Comparison of the predictive ability of albuminuria and dipstick proteinuria for mortality in the Japanese population: the Yamagata (Takahata) studyClinical and Experimental Nephrology, 20
Y. Yano, Yuji Sato, S. Fujimoto, T. Konta, K. Iseki, T. Moriyama, K. Yamagata, K. Tsuruya, H. Yoshida, K. Asahi, I. Kurahashi, Y. Ohashi, Tsuyoshi Watanabe (2012)
Association of High Pulse Pressure With Proteinuria in Subjects With Diabetes, Prediabetes, or Normal Glucose Tolerance in a Large Japanese General Population SampleDiabetes Care, 35
J. Coresh, T. Turin, K. Matsushita, Y. Sang, S. Ballew, L. Appel, H. Arima, S. Chadban, M. Cirillo, O. Djurdjev, J. Green, G. Heine, L. Inker, F. Irie, A. Ishani, J. Ix, C. Kovesdy, A. Marks, T. Ohkubo, V. Shalev, A. Shankar, C. Wen, P. Jong, K. Iseki, B. Stengel, R. Gansevoort, A. Levey (2014)
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.JAMA, 311 24
C. Wen, T. Cheng, M. Tsai, Yen-chen Chang, H. Chan, S. Tsai, P. Chiang, Chih-Cheng Hsu, P. Sung, Yi Hsu, S. Wen (2008)
All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in TaiwanThe Lancet, 371
Y. Yano, S. Fujimoto, H. Kramer, Yuji Sato, T. Konta, K. Iseki, C. Iseki, T. Moriyama, K. Yamagata, K. Tsuruya, I. Narita, M. Kondo, K. Kimura, K. Asahi, I. Kurahashi, Y. Ohashi, Tsuyoshi Watanabe (2015)
Long-Term Blood Pressure Variability, New-Onset Diabetes Mellitus, and New-Onset Chronic Kidney Disease in the Japanese General PopulationHypertension, 66
A. Levey, P. Jong, J. Coresh, M. Nahas, B. Astor, K. Matsushita, R. Gansevoort, B. Kasiske, K. Eckardt (2011)
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.Kidney international, 80 1
L. Boulware, B. Jaar, M. Tarver-Carr, F. Brancati, N. Powe (2003)
Screening for proteinuria in US adults: a cost-effectiveness analysis.JAMA, 290 23
D. Jager, M. Vervloet, F. Dekker (2014)
Noncardiovascular mortality in CKD: an epidemiological perspectiveNature Reviews Nephrology, 10
K. Matsushita, B. Mahmoodi, M. Woodward, J. Emberson, T. Jafar, S. Jee, K. Polkinghorne, A. Shankar, David Smith, M. Tonelli, D. Warnock, C. Wen, J. Coresh, R. Gansevoort, B. Hemmelgarn, A. Levey (2012)
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.JAMA, 307 18
K Iseki, T Konta, K Asahi (2018)
Glucosuria is associated with a higher risk of all-cause mortality in both diabetes mellitus and non diabetes mellitus subjects among a general screening cohortClin Exp Nephrol
M. Nagata, T. Ninomiya, Y. Kiyohara, Y. Murakami, F. Irie, T. Sairenchi, K. Miura, T. Okamura, H. Ueshima (2013)
Prediction of cardiovascular disease mortality by proteinuria and reduced kidney function: pooled analysis of 39,000 individuals from 7 cohort studies in Japan.American journal of epidemiology, 178 1
Pei-Hsuan Weng, K. Hung, Hsien-Liang Huang, Jen-Hau Chen, P. Sung, Kuo-Chin Huang (2011)
Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.Clinical journal of the American Society of Nephrology : CJASN, 6 5
H. Metoki, T. Ohkubo, M. Kikuya, K. Asayama, T. Obara, J. Hashimoto, K. Totsune, H. Hoshi, H. Satoh, Y. Imai (2006)
Prognostic Significance for Stroke of a Morning Pressor Surge and a Nocturnal Blood Pressure Decline: The Ohasama StudyHypertension, 47
A. Go, G. Chertow, Dongjie Fan, C. McCulloch, Chi-yuan Hsu (2004)
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.The New England journal of medicine, 351 13
B. Hemmelgarn, B. Manns, Anita Lloyd, M. James, S. Klarenbach, R. Quinn, N. Wiebe, M. Tonelli (2010)
Relation between kidney function, proteinuria, and adverse outcomes.JAMA, 303 5
E. Hoogeveen, J. Geleijnse, E. Giltay, S. Soedamah-Muthu, J. Goede, L. Griep, T. Stijnen, D. Kromhout (2017)
Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: A 10-year follow-up studyPLoS ONE, 12
W. Lowrance, J. Ordonez, N. Udaltsova, P. Russo, A. Go (2014)
CKD and the risk of incident cancer.Journal of the American Society of Nephrology : JASN, 25 10
R. Gansevoort, P. Jong, M. Postma (2004)
Cost-effectiveness of screening for proteinuria.JAMA, 291 12
T. Konta, Ami Ikeda, K. Ichikawa, S. Fujimoto, K. Iseki, T. Moriyama, K. Yamagata, K. Tsuruya, H. Yoshida, K. Asahi, I. Kurahashi, Y. Ohashi, Tsuyoshi Watanabe (2012)
Blood pressure control in a Japanese population with chronic kidney disease: a baseline survey of a nationwide cohort.American journal of hypertension, 25 3
K Matsushita (2010)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohortsLancet, 375
(2005)
Definition and the diagnostic standard for metabolic syndromeNihon Naika Gakkai Zasshi, 94
K. Iseki, K. Asahi, K. Yamagata, S. Fujimoto, K. Tsuruya, I. Narita, T. Konta, M. Kasahara, Y. Shibagaki, H. Yoshida, T. Moriyama, M. Kondo, C. Iseki, Tsuyoshi Watanabe, For Check” (2017)
Mortality risk among screened subjects of the specific health check and guidance program in Japan 2008–2012Clinical and Experimental Nephrology, 21
K. Matsushita, Marije Velde, B. Astor, M. Woodward, A. Levey, P. Jong, J. Coresh, R. Gansevoort (2010)
Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 375
K. Iseki, Yoshiharu Ikemiya, K. Kinjo, Taku Inoue, C. Iseki, S. Takishita (2004)
Body mass index and the risk of development of end-stage renal disease in a screened cohort.Kidney international, 65 5
C. Kovesdy, J. Coresh, S. Ballew, M. Woodward, A. Levin, David Naimark, J. Nally, D. Rothenbacher, B. Stengel, K. Iseki, K. Matsushita, A. Levey (2016)
Past Decline Versus Current eGFR and Subsequent ESRD Risk.Journal of the American Society of Nephrology : JASN, 27 8
L. Jørgensen, Ivar Heuch, T. Jenssen, B. Jacobsen (2008)
Association of albuminuria and cancer incidence.Journal of the American Society of Nephrology : JASN, 19 5
K. Yamagata, H. Makino, K. Iseki, S. Ito, K. Kimura, E. Kusano, T. Shibata, K. Tomita, I. Narita, T. Nishino, Y. Fujigaki, T. Mitarai, Tsuyoshi Watanabe, T. Wada, Teiji Nakamura, S. Matsuo (2016)
Effect of Behavior Modification on Outcome in Early- to Moderate-Stage Chronic Kidney Disease: A Cluster-Randomized TrialPLoS ONE, 11
V. Perkovic, R. Agarwal, P. Fioretto, B. Hemmelgarn, A. Levin, Merlin Thomas, C. Wanner, B. Kasiske, D. Wheeler, P. Groop (2016)
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.Kidney international, 90 6
K Tsuruya, H Yoshida, M Nagata, T Kitazono, K Iseki, C Iseki (2015)
Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of chronic kidney disease: a longitudinal study in a large Japanese populationAm J Kidney Dis, 66
K. Iseki, T. Konta, K. Asahi, K. Yamagata, S. Fujimoto, K. Tsuruya, I. Narita, M. Kasahara, Y. Shibagaki, T. Moriyama, M. Kondo, C. Iseki, Tsuyoshi Watanabe, For Check” (2018)
Glucosuria and all-cause mortality among general screening participantsClinical and Experimental Nephrology, 22
S. Hallan, K. Matsushita, Y. Sang, B. Mahmoodi, C. Black, A. Ishani, N. Kleefstra, David Naimark, P. Roderick, M. Tonelli, J. Wetzels, B. Astor, R. Gansevoort, A. Levin, C. Wen, J. Coresh (2012)
Age and association of kidney measures with mortality and end-stage renal disease.JAMA, 308 22
S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, K. Nitta, K. Yamagata, Y. Tomino, H. Yokoyama, A. Hishida (2009)
Revised equations for estimated GFR from serum creatinine in Japan.American journal of kidney diseases : the official journal of the National Kidney Foundation, 53 6
K. Iseki, Yoshiharu Ikemiya, C. Iseki, S. Takishita (2003)
Proteinuria and the risk of developing end-stage renal disease.Kidney international, 63 4
V. Jha, M. Arıcı, A. Collins, G. García-García, B. Hemmelgarn, T. Jafar, R. Pecoits-Filho, L. Solá, C. Swanepoel, I. Tchokhonelidze, A. Wang, B. Kasiske, D. Wheeler, G. Spasovski (2016)
Understanding kidney care needs and implementation strategies in low- and middle-income countries: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.Kidney international, 90 6
S. Tanihara, T. Hayakawa, I. Oki, Yosikazu Nakamura, K. Sakata, A. Okayama, Y. Fujita, H. Ueshima (2005)
Proteinuria is a Prognostic Marker for Cardiovascular Mortality: NIPPON DATA 80, 1980-1999Journal of Epidemiology, 15
G. Wong, N. Staplin, J. Emberson, C. Baigent, R. Turner, J. Chalmers, S. Zoungas, C. Pollock, B. Cooper, D. Harris, Jie-Jin Wang, P. Mitchell, R. Prince, W. Lim, J. Lewis, J. Chapman, J. Craig (2016)
Chronic kidney disease and the risk of cancer: an individual patient data meta-analysis of 32,057 participants from six prospective studiesBMC Cancer, 16
K. Iseki, Yoshiharu Ikemiya, Koshiro Fukiyama (1997)
Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening.Kidney international, 51 3
M. Wakasugi, J. Kazama, I. Narita, K. Iseki, S. Fujimoto, T. Moriyama, K. Yamagata, T. Konta, K. Tsuruya, K. Asahi, M. Kondo, I. Kurahashi, Y. Ohashi, K. Kimura, Tsuyoshi Watanabe (2017)
Association between Overall Lifestyle Changes and the Incidence of Proteinuria: A Population-based, Cohort StudyInternal Medicine, 56
Background Dipstick proteinuria, but not albuminuria, is used for general health screening in Japan. How the results of dipstick proteinuria tests correlate with mortality and, however, is not known. Methods Subjects were participants of the 2008 Tokutei-Kenshin (Specific Health Check and Guidance program) in six districts in Japan. On the basis of the national database of death certificates from 2008 to 2012, we used a personal identifier in two computer registries to identify participants who might have died. The hazard ratio (95% confidence interval, CI) was calculated by Cox-proportional hazard analysis. Results Among a total of 140,761 subjects, we identified 1641 mortalities that occurred by the end of 2012. The crude mortality rates were 1.1% for subjects who were proteinuria (−), 1.5% for those with proteinuria (+/−), 2.0% for those with proteinuria (1+), 3.5% for those with proteinuria (2+), and 3.7% for those with proteinuria (≥ 3+). After adjusting for sex, age, body mass index, estimated glomerular filtration rate, comorbid condition, past history, and lifestyle, the hazard ratio (95% CI) for dipstick proteinuria was 1.262 (1.079–1.467) for those with proteinuria (+/−), 1.437 (1.168–1.748) for those with proteinuria (1+), 2.201 (1.688–2.867) for those with proteinuria (2+), and 2.222 (1.418–3.301) for
Clinical and Experimental Nephrology – Springer Journals
Published: Jun 5, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.